1. Integrative analysis of aging-related genes reveals CEBPA as a novel therapeutic target in non-small cell lung cancer
- Author
-
Jiaqi Zhu, Xiaoren Zhu, Conglin Shi, Qixuan Li, Yun Jiang, Xingyou Chen, Pingping Sun, Yi Jin, Tianyi Wang, and Jianle Chen
- Subjects
Non-small cell lung cancer ,Prognostic model ,LASSO regression ,Tumor immune microenvironment ,Therapeutic target ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 ,Cytology ,QH573-671 - Abstract
Abstract Background To explore the impact of ARGs on the prognosis of NSCLC, and its correlation with clinicopathological parameters and immune microenvironment. Preliminary research on the biological functions of CEBPA in NSCLC. Methods Using consensus clustering analysis to identify molecular subtypes of ARGs in NSCLC patients; employing LASSO regression and multivariate Cox analysis to select 7 prognostic risk genes and construct a prognostic risk model; validating independent prognostic factors of NSCLC using forest plot analysis; analyzing immune microenvironment correlations using ESTIMATE and ssGSEA; assessing correlations between prognostic risk genes via qPCR and Western blot in NSCLC; measuring mRNA and protein expression levels of knocked down and overexpressed CEBPA in NSCLC using CCK-8 and EdU assays; evaluating the effects of knocked down and overexpressed CEBPA on cell proliferation using Transwell experiments; examining the correlation of CEBPA with T cells and B cells using mIHC analysis. Results Consensus clustering analysis identified three molecular subtypes, suggesting significant differential expression of these ARGs in NSCLC prognosis and clinical pathological parameters. There was significant differential expression between the two risk groups in the prognostic risk model, with P
- Published
- 2024
- Full Text
- View/download PDF